SRPT

Sarepta Therapeutics, Inc. News Headlines

$16.81
*  
0.29
1.76%
Get SRPT Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Health Care Sector Update for 11/26/2014: SRPT,RNA,BMRN,BDX,MRGE
11/26/2014 4:00:03 PM - MT Newswires


Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog
11/25/2014 6:56:00 PM - Zacks.com


Rolling With Biotech's Regulatory Punches: Chen Lin
11/25/2014 4:36:00 PM - Seeking Alpha


Marina Biotech: A Forgotten And Grossly Undervalued Game Changer
11/25/2014 11:40:00 AM - Seeking Alpha


BioMarin Takes Aim at Sarepta
11/25/2014 11:02:08 AM - Motley Fool


Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer
11/25/2014 10:30:00 AM - Seeking Alpha


Marina Biotech: A Forgotten And Grossly Undervalued Game Changer
11/25/2014 10:30:00 AM - SeekingAlpha


BioMarin Acquires Prosensa in Deal Valued Up to $840 Million
11/24/2014 6:34:00 AM - TheStreet


Celldex Therapeutics To Enter Talks With FDA
11/18/2014 10:26:00 AM - Seeking Alpha


Sarepta Initiates Dosing for Study Evaluating Eteplirsen - Analyst Blog
11/13/2014 5:40:00 PM - Zacks.com


Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak
11/13/2014 4:24:00 PM - Seeking Alpha


Sarepta Q3 Loss Narrower-Than-Expected, Eteplirsen in Focus - Analyst Blog
11/10/2014 12:40:00 PM - Zacks.com


Why Sarepta Therapeutics Inc. Stock Imploded in October
11/7/2014 8:04:06 AM - Motley Fool


Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx
10/31/2014 6:40:00 AM - TheStreet


5 Stocks To Consider When Playing Ebola
10/29/2014 11:31:00 AM - Seeking Alpha


Sarepta Slumps as Eteplirsen NDA Submission Gets Delayed - Analyst Blog
10/28/2014 1:22:00 PM - Zacks.com


Sarepta Slumps: SRPT Plunges 32.5% in Session - Tale of the Tape
10/28/2014 7:49:00 AM - Zacks.com


Sector Update: Health Care Stocks Little Changed; Sarepta Therapeutics Slammed After FDA Asks for More Data on Eteplirsen Drug Candidate
10/27/2014 12:44:21 PM - MT Newswires


Sector Update: Health Care
10/27/2014 12:41:50 PM - MT Newswires


Midday Update: Stocks FluctuatingToday As Pressure on Energy Sector Offset By Technical Support
10/27/2014 11:40:22 AM - MT Newswires


Sarepta Therapeutics Inc. (SRPT) Has Fallen To An 11-Month Low On FDA News
10/27/2014 9:33:00 AM - RTT News


Why Sarepta Therapeutics Inc Stock Is Crashing Today
10/27/2014 9:31:08 AM - Motley Fool


Ebola Hits NYC: Time To Panic
10/27/2014 8:45:00 AM - Seeking Alpha


Pre-Market Most Active for Oct 27, 2014 : PBR, BSBR, SAN, NOK, PBR/A, CQB, SRPT, MU, QQQ, NVAX, FB, TVIX
10/27/2014 7:38:58 AM - NASDAQ.com News


Why I Won't Buy Ebola Stocks
10/27/2014 7:31:03 AM - Motley Fool